More Articles

Patients and Medical

Five Reasons Why Clinical Trials Fail And What Pharma is Doing To Fix It

Adam Chapman, (Jul 27, 2018)

Clinical trial recruitment is a perennial challenge for pharma. Are they listening to patients?
Access and Evidence

United: How employers are changing healthcare

Hugh Gosling, (Jul 27, 2018)

The growth in employer coalitions are a sign that plan sponsors are increasingly flexing their muscles, but what do they hope to achieve?
Patients and Medical

Six Ways Artificial Intelligence Is Impacting Patients

Lucy Fulford, (Jul 24, 2018)

AI is no longer the stuff of science fiction – it’s impacting patients today
Access and Evidence

Writing the Value Story

Adam Chapman, (Jul 19, 2018)

When writing the value story for a new medicine, starting earlier in Development will make sure it’s a page-turner
Patients and Medical

Tackling Stigma

Lucy Fulford, (Jul 17, 2018)

How pharma and patient groups are tackling negative attitudes around health

How Do You Localize A Global Brand Strategy?

Adam Chapman, (Jul 16, 2018)

Marketers must balance global and local needs in their campaigns. How do they pull it off?
Patients and Medical

Could HCPs Hold The Key To Adherence?

Danielle Barron, (Jul 5, 2018)

The connection between a HCP and a patient is profound. How can it be harnessed?

Why MSLs And Sales Reps Should Join Forces

Katie Osborne, (Jun 26, 2018)

The case for aligning MSLs with sales reps is strong — if both sides play ball.
Access and Evidence

Pragmatic Trials: RWE’s Hidden Gem

Ross Davies, (Jun 20, 2018)

Pragmatic trials continue to be overlooked in the RWE space – particularly in the US. Can we expect to see wider stateside adoption?

The Big Trends Transforming Pharma

Adam Chapman, (Jun 15, 2018)

The industry is fast approaching a promising new future. How is it getting there?